The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
C-POST protocol update: A phase 3, randomized, double-blind study of adjuvant cemiplimab versus placebo post-surgery and radiation therapy (RT) in patients (pts) with high-risk cutaneous squamous cell carcinoma (CSCC).
 
Danny Rischin
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Kura Oncology (Inst); Merck (Inst); Merck KGaA (Inst); Regeneron (Inst); Sanofi (Inst)
(OPTIONAL) Uncompensated Relationships - GlaxoSmithKline; Merck; Regeneron; Sanofi
 
Daniel Brungs
No Relationships to Disclose
 
Fiona Day
Consulting or Advisory Role - Amgen
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb; Varian Medical Systems
 
Hayden Robert Christie
No Relationships to Disclose
 
Vishal A. Patel
Stock and Other Ownership Interests - Science 37
Honoraria - Medscape; SanovaWorks
Consulting or Advisory Role - Almirall; Jounce Therapeutics; Regeneron; Sanofi
Speakers' Bureau - Regeneron; Sanofi
 
Gerard Adams
Employment - Genesis Cancer Care
 
James Estes Jackson
No Relationships to Disclose
 
Maite De Liz Vassen Schurmann
No Relationships to Disclose
 
Dmitry Kirtbaya
No Relationships to Disclose
 
Thuzar M. Shin
No Relationships to Disclose
 
Christopher David Hart
No Relationships to Disclose
 
Elizabeth Stankevich
Employment - Regeneron
Stock and Other Ownership Interests - Bristol-Myers Squibb; Merck; Regeneron
 
Siyu Li
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Israel Lowy
Employment - Regeneron
Leadership - Regeneron
Stock and Other Ownership Interests - Regeneron
Patents, Royalties, Other Intellectual Property - Regeneron
 
Hyunsil Han
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Matthew G. Fury
Employment - Regeneron; Regeneron (I)
Stock and Other Ownership Interests - Regeneron; Regeneron (I)
Research Funding - Regeneron
Patents, Royalties, Other Intellectual Property - Regeneorn; Regeneron (I)
 
Sandro Porceddu
Leadership - Icon Cancer Center
Stock and Other Ownership Interests - Icon Cancer Care (I)
Consulting or Advisory Role - Merck Serono; Merck Sharp & Dohme; Regeneron; UpToDate
Travel, Accommodations, Expenses - Merck Serono; Merck Sharp & Dohme